---
title: "New Stock Margin Financing Statistics | June 24"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/290684772.md"
description: "TH MEDICAL-B, LAIFUAL, XUNLONG SCITECH, JIANGXI BIO, and ANKER are currently in the process of going public. As of June 24, Futu Securities, Phillip Securities, and other brokerages have lent HKD 4.707 billion for TH MEDICAL-B, with an oversubscription of over 96.51 times; lent HKD 28.156 billion for LAIFUAL, with an oversubscription of over 488.97 times; lent HKD 24.746 billion for XUNLONG SCITECH, with an oversubscription of over 199.67 times; lent HKD 2.865 billion for JIANGXI BIO, with an oversubscription of over 59.53 times; and lent HKD 937 million for ANKER, with an oversubscription of over 1.02 times"
datetime: "2026-06-24T11:15:53.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/290684772.md)
  - [en](https://longbridge.com/en/news/290684772.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/290684772.md)
---

# New Stock Margin Financing Statistics | June 24

According to Zhitong Finance APP, TH MEDICAL-B (02697), LAIFUAL (03952), XUNLONG SCITECH (06715), JIANGXI BIO (06915), and ANKER (00668) are currently in the process of going public. As of June 24, Futu Securities, Phillip Securities, and other brokerages have lent HKD 4.707 billion for TH MEDICAL-B, with an oversubscription of over 96.51 times; lent HKD 28.156 billion for LAIFUAL, with an oversubscription of over 488.97 times; lent HKD 24.746 billion for XUNLONG SCITECH, with an oversubscription of over 199.67 times; lent HKD 2.865 billion for JIANGXI BIO, with an oversubscription of over 59.53 times; and lent HKD 937 million for ANKER, with an oversubscription of over 1.02 times.

![image.png](https://imageproxy.pbkrs.com/https://img.zhitongcaijing.com/image/20260624/1782299039382762.png?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg)

![image.png](https://imageproxy.pbkrs.com/https://img.zhitongcaijing.com/image/20260624/1782299077943604.png?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg)

![image.png](https://imageproxy.pbkrs.com/https://img.zhitongcaijing.com/image/20260624/1782299394561028.png?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg)

![image.png](https://imageproxy.pbkrs.com/https://img.zhitongcaijing.com/image/20260624/1782299110244292.png?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg)

![image.png](https://imageproxy.pbkrs.com/https://img.zhitongcaijing.com/image/20260624/1782299504237080.png?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg)

### Related Stocks

- [02697.HK](https://longbridge.com/en/quote/02697.HK.md)
- [300866.CN](https://longbridge.com/en/quote/300866.CN.md)
- [03952.HK](https://longbridge.com/en/quote/03952.HK.md)
- [06715.HK](https://longbridge.com/en/quote/06715.HK.md)
- [00668.HK](https://longbridge.com/en/quote/00668.HK.md)
- [06915.HK](https://longbridge.com/en/quote/06915.HK.md)
- [FUTU.US](https://longbridge.com/en/quote/FUTU.US.md)
- [03588.HK](https://longbridge.com/en/quote/03588.HK.md)

## Related News & Research

- [ZhenHealth's HK IPO tests global appetite for pre-revenue medical assets](https://longbridge.com/en/news/290939539.md)
- [Anker Innovations announces the listing plan on the Main Board of HKEX with a maximum fundraising of HK$4,631.6 Million](https://longbridge.com/en/news/290506756.md)
- [ZAWYA: Abu Dhabi Biobank and BioTwin announce strategic partnership to expand human virtual twin technology in the UAE](https://longbridge.com/en/news/290948225.md)
- [ZAWYA: Mubadala Bio partners with Biosidus to advance access to biologic therapies](https://longbridge.com/en/news/290931629.md)
- [Prime Day 2026: Top Savings on Anker, Beats, TVs, and More Accessories](https://longbridge.com/en/news/290693995.md)